Wellcome Trust Centre for Neuroimaging at UCL

Details
Medical Suppliers In Greater London

Name :

Wellcome Trust Centre for Neuroimaging at UCL

Address  :

12 Queen Square

Town  :

London

State  :

Greater London

Country  :

UK

Post Code:

WC1N 3BG

Phone  :

+44 (0)20 3448 4362

Fax  :

+44 (0)20 7813 1420

Web URL  :

Available

Email  :

h.dayantis@ucl.ac.uk
Specialization
Information not available, if you are owner/employee of Wellcome Trust Centre for Neuroimaging at UCL Please click to update hospital details.
Facilities

Other Facilities

  • X-Ray
  • Ultrasonography
  • CT/MRI

History
The Functional Imaging Laboratory FIL was founded in 1994 following a major grant award from the Wellcome Trust This provided for a new building capital equipment and core staff support

The award enabled a core group of scientists based at the Medical Research Council Cyclotron Unit at the Hammersmith Hospital to relocate their activity to a central London site within UCL

In 1994 the principal neuroimaging research tool was Positron Emission Tomography PET Over the next decade functional magnetic resonance imaging fMRI beceme the primary investigative tool of the FIL leading to PET decommissioning in 2004

Currently the investigative tools of the laboratory include functional magnetic resonance imaging fMRI magnetoencephalography MEG and electroencephalography EEG The laboratory has continued to enjoy core Wellcome Trust infrastructure support through major grant awards in 1999 and 2004

In 2006 following a successful bid for a Strategic Award the laboratory was awarded Wellcome Trust Centre status and is now known as the Wellcome Trust Centre for Neuroimaging at UCL
NEWS
Inadequate NHS diabetes care causing patients harm

NHS diabetes care is inadequate and some patients come to further harm due to poor care in hospital a leading specialist says Dr Gerry Rayman national clinical lead for inpatient diabetes warned many hospitals had no specialist diabetes nurse He said many hospital patients had diabetes and called the situation quite alarming The Department... Read More

ARTICLES
Statins cut risk of bowel cancer Danger halved by cholesterolbusting pills

Pills taken by up to seven million Britons to combat high cholesterol could more than halve the risk of bowel cancer according to researchers Statins which cost as little as 40p a day slashed the chances of the disease developing by an average of 57 per cent And in patients taking higher doses of the cholesterolbusting drugs or were on them for ... Read More